Matrix regulation of tumor-initiating cells

Progress in Molecular Biology and Translational Science

Volumn 126, Issue , 2014, Pages 243-256

  Wong, Sophie Y ^a   Kumar, Sanjay ^a  

^a University of California at Berkeley   (United States)

Author keywords

Cellular mechanotransduction; Extracellular matrix; Glioblastoma; Tumor invasion; Tumor initiating cells

Indexed keywords

ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL EXPANSION; CELL FUNCTION; CELL ISOLATION; CULTURE TECHNIQUE; EXTRACELLULAR MATRIX; HUMAN; MECHANOTRANSDUCTION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INITIATING CELL; TUMOR MICROENVIRONMENT; ANIMAL; CELL ADHESION; CELL SEPARATION; METABOLISM; PATHOLOGY;

ANIMALS; CELL ADHESION; CELL SEPARATION; EXTRACELLULAR MATRIX; HUMANS; MECHANOTRANSDUCTION, CELLULAR; NEOPLASTIC STEM CELLS;

EID: 84905174219     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394624-9.00010-5     Document Type: Chapter

References (62)

1. R. Rouzier, C.M. Perou, and W.F. Symmans et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 16 2005 5678 5685 10.1158/1078-0432.CCR-04-2421 (Pubitemid 41170290)
2. J.A. Magee, E. Piskounova, and S.J. Morrison Cancer stem cells: impact, heterogeneity, and uncertainty Cancer Cell 21 3 2012 283 296 10.1016/j.ccr.2012.03.003
3. S. Banerjee, J.S. Reis-Filho, and S. Ashley et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy J Clin Pathol 59 7 2006 729 735 10.1136/jcp.2005.033043 (Pubitemid 44048783)
4. T. Lapidot, C. Sirard, and J. Vormoor et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 6464 1994 645 648 10.1038/367645a0 (Pubitemid 24067706)
5. L.P. Deleyrolle, A. Harding, and K. Cato et al. Evidence for label-retaining tumour-initiating cells in human glioblastoma Brain 134 5 2011 1331 1343 10.1093/brain/awr081
6. P.B. Dirks Brain tumor stem cells: the cancer stem cell hypothesis writ large Mol Oncol 4 5 2010 420 430 10.1016/j.molonc.2010.08.001
7. L. Vermeulen, F. de Sousa e Melo, D.J. Richel, and J.P. Medema The developing cancer stem-cell model: clinical challenges and opportunities Lancet Oncol 13 2 2012 e83 e89
8. F. Vaillant, M.-L. Asselin-Labat, M. Shackleton, N.C. Forrest, G.J. Lindeman, and J.E. Visvader The mammary progenitor marker CD61/β3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis Cancer Res 68 19 2008 7711 7717 10.1158/0008-5472.CAN-08-1949
9. D. Ponti, A. Costa, and N. Zaffaroni et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res 65 13 2005 5506 5511 10.1158/0008-5472.CAN-05-0626 (Pubitemid 40911148)
10. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 23 2005 10946 10951 10.1158/0008-5472.CAN-05-2018 (Pubitemid 41713363)
11. L. Patrawala, T. Calhoun-Davis, R. Schneider-Broussard, and D.G. Tang Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+α2β1 + cell population is enriched in tumor-initiating cells Cancer Res 67 14 2007 6796 6805 10.1158/0008-5472.CAN-07-0490 (Pubitemid 47105527)
12. A. Eramo, F. Lotti, and G. Sette et al. Identification and expansion of the tumorigenic lung cancer stem cell population Cell Death Differ 15 3 2007 504 514 10.1038/sj.cdd.4402283
13. F. Beier, C.P. Beier, I. Aschenbrenner, G.C. Hildebrandt, T.H. Brümmendorf, and D. Beier Identification of CD133 -/telomerase low progenitor cells in glioblastoma-derived cancer stem cell lines Cell Mol Neurobiol 31 3 2010 337 343 10.1007/s10571-010-9627-4
14. Q. Huang, Q.-B. Zhang, and J. Dong et al. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro BMC Cancer 8 2008 304 10.1186/1471-2407-8-304
15. B. Beck, and C. Blanpain Unravelling cancer stem cell potential Nat Rev Cancer 13 10 2013 727 738 10.1038/nrc3597
16. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 6859 2001 105 111 10.1038/35102167 (Pubitemid 33041634)
17. C.T. Jordan, M.L. Guzman, and M. Noble Cancer stem cells N Engl J Med 355 12 2006 1253 1261 10.1056/NEJMra061808 (Pubitemid 44427449)
18. A. Sottoriva, I. Spiteri, D. Shibata, C. Curtis, and S. Tavaré Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization Cancer Res 73 1 2013 41 49 10.1158/0008-5472.CAN- 12-2273
19. M. Nakada, S. Nakada, T. Demuth, N.L. Tran, D.B. Hoelzinger, and M.E. Berens Molecular targets of glioma invasion Cell Mol Life Sci 64 4 2007 458 478 10.1007/s00018-007-6342-5
20. R. Galli, E. Binda, and U. Orfanelli et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res 64 19 2004 7011 7021 10.1158/0008-5472.CAN-04-1364 (Pubitemid 39331011)
21. S.M. Pollard, K. Yoshikawa, and I.D. Clarke et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens Cell Stem Cell 4 6 2009 568 580 10.1016/j.stem.2009.03.014
22. J. Lee, S. Kotliarova, and Y. Kotliarov et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines Cancer Cell 9 5 2006 391 403 10.1016/j.ccr.2006.03.030 (Pubitemid 43668737)
23. P. Kleihues, and L.H. Sobin World Health Organization classification of tumors Cancer 88 12 2000 2887 10.1002/1097-0142(20000615)88:12<2887::AID- CNCR32>3.0.CO;2-F (Pubitemid 30417954)
24. J.D. Lathia, J.M. Heddleston, M. Venere, and J.N. Rich Deadly teamwork: neural cancer stem cells and the tumor microenvironment Cell Stem Cell 8 5 2011 482 485 10.1016/j.stem.2011.04.013
25. S.P. Niclou, C. Danzeisen, and H.P. Eikesdal et al. A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions FASEB J 22 9 2008 3120 3128 10.1096/fj.08-109611
26. J.D. Lathia, J. Gallagher, and J.T. Myers et al. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells PLoS One 6 9 2011 e24807 10.1371/journal.pone.0024807
27. F. Zeppernick, R. Ahmadi, and B. Campos et al. Stem cell marker CD133 affects clinical outcome in glioma patients Clin Cancer Res 14 1 2008 123 129 10.1158/1078-0432.CCR-07-0932 (Pubitemid 351377986)
28. T. Strojnik, G.V. Røsland, P.O. Sakariassen, R. Kavalar, and T. Lah Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival Surg Neurol 68 2 2007 133 143 10.1016/j.surneu.2006.10.050 (Pubitemid 47087905)
29. S.K. Singh, C. Hawkins, and I.D. Clarke et al. Identification of human brain tumour initiating cells Nature 432 7015 2004 396 401 10.1038/nature03128 (Pubitemid 39551674)
30. M.J. Son, K. Woolard, D.-H. Nam, J. Lee, and H.A. Fine SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma Cell Stem Cell 4 5 2009 440 452 10.1016/j.stem.2009.03.003
31. A.T.M.D. Ogden, A.E.M.D. Waziri, and R.A. Lochhead et al. Identification of A2B5+CD133 - tumor-initiating cells in adult human gliomas Neurosurgery 62 2 2008 505 515 10.1227/01.neu.0000316019.28421.95 [Miscellaneous Article]
32. J.D. Lathia, J. Gallagher, and J.M. Heddleston et al. Integrin alpha 6 regulates glioblastoma stem cells Cell Stem Cell 6 5 2010 421 432 10.1016/j.stem.2010.02.018
33. V. Clément, V. Dutoit, D. Marino, P.-Y. Dietrich, and I. Radovanovic Limits of CD133 as a marker of glioma self-renewing cells Int J Cancer 125 1 2009 244 248 10.1002/ijc.24352
34. S.K. Hermansen, K.G. Christensen, S.S. Jensen, and B.W. Kristensen Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma J Histochem Cytochem 59 4 2011 391 407 10.1369/0022155411400867
35. A.B. Lyons Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution J Immunol Methods 243 1-2 2000 147 154 10.1016/S0022-1759(00)00231-3
36. M. Venere, H.A. Fine, P.B. Dirks, and J.N. Rich Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy Glia 59 8 2011 1148 1154 10.1002/glia.21185
37. M. Nakada, E. Nambu, and N. Furuyama et al. Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion Br J Cancer 108 12 2013 2516 2524 10.1038/bjc.2013.218
38. X. Zhu, F.C. Morales, N.K. Agarwal, T. Dogruluk, M. Gagea, and M.-M. Georgescu Moesin is a glioma progression marker that induces proliferation and Wnt/β-catenin pathway activation via interaction with CD44 Cancer Res 73 3 2013 1142 1155 10.1158/0008-5472.CAN-12-1040
39. R. Marhaba, and M. Zöller CD44 in cancer progression: adhesion, migration and growth regulation J Mol Histol 35 3 2004 211 231 10.1023/B:HIJO.0000032354.94213.69 (Pubitemid 40585308)
40. M. Jijiwa, H. Demir, and S. Gupta et al. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway PLoS One 6 9 2011 e24217 10.1371/journal.pone.0024217
41. T.A. Ulrich, E.M. de Juan Pardo, and S. Kumar The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells Cancer Res 69 10 2009 4167 4174 10.1158/0008-5472.CAN-08-4859
42. A.J. Engler, S. Sen, H.L. Sweeney, and D.E. Discher Matrix elasticity directs stem cell lineage specification Cell 126 4 2006 677 689 10.1016/j.cell.2006.06.044 (Pubitemid 44233625)
43. R.W. Tilghman, C.R. Cowan, and J.D. Mih et al. Matrix rigidity regulates cancer cell growth and cellular phenotype PLoS One 5 9 2010 e12905 10.1371/journal.pone.0012905
44. P.C. Georges, and P.A. Janmey Cell type-specific response to growth on soft materials J Appl Physiol 98 4 2005 1547 1553 10.1152/japplphysiol.01121. 2004 (Pubitemid 40396536)
45. C.-M. Cheng, R.L. Steward Jr., and P.R. LeDuc Probing cell structure by controlling the mechanical environment with cell-substrate interactions J Biomech 42 2 2009 187 192 10.1016/j.jbiomech.2008.10.014
46. T. Yeung, P.C. Georges, and L.A. Flanagan et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion Cell Motil Cytoskeleton 60 1 2005 24 34 10.1002/cm.20041 (Pubitemid 40066224)
47. A.J. Keung, S. Kumar, and D.V. Schaffer Presentation counts: microenvironmental regulation of stem cells by biophysical and material cues Annu Rev Cell Dev Biol 26 1 2010 533 556 10.1146/annurev-cellbio-100109-104042
48. A.J. Keung, E.M. de Juan-Pardo, D.V. Schaffer, and S. Kumar Rho GTPases mediate the mechanosensitive lineage commitment of neural stem cells Stem Cells 29 11 2011 1886 1897 10.1002/stem.746
49. K. Woolard, and H.A. Fine Glioma stem cells: better flat than round Cell Stem Cell 4 6 2009 466 467 10.1016/j.stem.2009.05.013
50. L.P. Deleyrolle, and B.A. Reynolds Identifying and enumerating neural stem cells: application to aging and cancer J. Verhaagen, E.M. Hol, I. Huitenga, J. Wijnholds, A.B. Bergen, G.J. Boer, D.F. Swaab, Neurotherapy: progress in restorative neuroscience and neurology Vol. 175 2009 Elsevier New York, NY 43 51 Available at: http://www.sciencedirect.com/science/article/B7CV6-4WXGYYC-9/2/ e6a7879250e9bf6126f9504ae6c027ce. Accessed April 5, 2011
51. H. Azari, S. Millette, S. Ansari, M. Rahman, L.P. Deleyrolle, and B.A. Reynolds Isolation and expansion of human glioblastoma multiforme tumor cells using the neurosphere assay J Vis Exp 56 2011 e3633 10.3791/3633
52. D.A. Reardon, L.B. Nabors, R. Stupp, and T. Mikkelsen Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme Expert Opin Investig Drugs 17 8 2008 1225 1235 10.1517/13543784.17.8.1225
53. Y. Terakawa, S. Agnihotri, and B. Golbourn et al. The role of drebrin in glioma migration and invasion Exp Cell Res 319 4 2013 517 528 10.1016/j.yexcr.2012.11.008
54. A. Natsume, T. Kato, and S. Kinjo et al. Girdin maintains the stemness of glioblastoma stem cells Oncogene 31 22 2012 2715 2724 10.1038/onc.2011.466
55. K. Kobayashi, H. Takahashi, and A. Inoue et al. Oct-3/4 promotes migration and invasion of glioblastoma cells J Cell Biochem 113 2 2012 508 517 10.1002/jcb.23374
56. M.M. Alonso, R. Diez-Valle, and L. Manterola et al. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas PLoS One 6 11 2011 e26740 10.1371/journal.pone.0026740
57. F. Oppel, N. Müller, and G. Schackert et al. SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells Mol Cancer 10 2011 137 10.1186/1476-4598-10-137
58. F.A. Siebzehnrubl, D.J. Silver, and B. Tugertimur et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance EMBO Mol Med 5 8 2013 1196 1212 10.1002/emmm.201302827
59. L.A. Edwards, K. Woolard, and M.J. Son et al. Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion J Natl Cancer Inst 103 15 2011 1162 1178 10.1093/jnci/djr224
60. A. Enomoto, J. Ping, and M. Takahashi Girdin, a novel actin-binding protein, and its family of proteins possess versatile functions in the Akt and Wnt signaling pathways Ann NY Acad Sci 1086 1 2006 169 184 10.1196/annals.1377. 016 (Pubitemid 47084384)
61. P. Jiang, A. Enomoto, and M. Jijiwa et al. An actin-binding protein girdin regulates the motility of breast cancer cells Cancer Res 68 5 2008 1310 1318 10.1158/0008-5472.CAN-07-5111 (Pubitemid 351346837)
62. J. Liu, Y. Tan, and H. Zhang et al. Soft fibrin gels promote selection and growth of tumorigenic cells Nat Mater 11 8 2012 734 741 10.1038/nmat3361